(15023909), A. N. S., (15031292), A. J. O., (15051200), M. N., (15051203), T. J. H., (15032924), J. D. W., (15051206), V. L., . . . (15051215), M. J. (2025). Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma.
Chicago-čujuhus (17. p.)(15023909), Alexander N. Shoushtari, Anthony J. Olszanski (15031292), Marta Nyakas (15051200), Thomas J. Hornyak (15051203), Jedd D. Wolchok (15032924), Victor Levitsky (15051206), Lukasz Kuryk (15051209), Thomas B. Hansen (15051212), juo Magnus Jäderberg (15051215). Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma. 2025.
MLA-čujuhus (9. p.)(15023909), Alexander N. Shoushtari, et al. Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma. 2025.